Arrowhead Pharmaceuticals, Inc (ARWR) insider trading
Every open-market stock purchase and sale by Arrowhead Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Michael S Perry (Director) and 1 other sold $1.2M in the last 90 days.
- Last insider buy: Hongbo Lu (Director), $27.5K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $37.3M (19 sales). Last close $58.36 on Oct 22, 2026.
Recent ARWR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 18, 2026 | Michael S Perry (Director) | Sold | $1M |
| Aug 18, 2026 | Adeoye Y Olukotun (Director) | Sold | $174K |
| Jun 15, 2026 | Matthew Gregory Cohen (Director) | Bought (not open market) | — |
| May 12, 2026 | Hongbo Lu (Director) | Sold | $228K |
| Apr 23, 2026 | James C Hamilton (C-suite exec) | Sold | $750K |
| Apr 22, 2026 | Daniel Joseph Apel (CFO) | Sold | $628K |
| Apr 22, 2026 | Daniel Joseph Apel (CFO) | Sold | $225K |
| Apr 22, 2026 | Daniel Joseph Apel (CFO) | Sold | $81.5K |
| Mar 5, 2026 | James C Hamilton (C-suite exec) | Sold | $642K |
| Jan 6, 2026 | Patrick O'Brien (COO) | Sold (not open market) | — |
| Jan 6, 2026 | James C Hamilton (C-suite exec) | Bought (not open market) | — |
| Jan 6, 2026 | Patrick O'Brien (COO) | Sold (not open market) | — |
| Jan 6, 2026 | Daniel Joseph Apel (CFO) | Bought (not open market) | — |
| Jan 6, 2026 | Patrick O'Brien (COO) | Bought (not open market) | — |
| Jan 5, 2026 | James C Hamilton (C-suite exec) | Sold | $932K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $847K |
| Jan 5, 2026 | James C Hamilton (C-suite exec) | Sold | $813K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $756K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $384K |
| Jan 5, 2026 | James C Hamilton (C-suite exec) | Sold | $379K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $369K |
| Jan 5, 2026 | James C Hamilton (C-suite exec) | Sold | $283K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $267K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $174K |
| Jan 5, 2026 | Patrick O'Brien (COO) | Sold | $150K |
Who's trading ARWR
- Michael S Perry, Director: sold $2M (2 sales), last Aug 18, 2026
- Adeoye Y Olukotun, Director: sold $851K (4 sales), last Aug 18, 2026
- Matthew Gregory Cohen, Director: other filings, last Jun 15, 2026
- Hongbo Lu, Director: sold $228K (1 sale), last May 12, 2026
- James C Hamilton, C-suite exec: sold $3.9M (9 sales), last Apr 23, 2026
- Daniel Joseph Apel, CFO: sold $934K (3 sales), last Apr 22, 2026
- Patrick O'Brien, COO: sold $3.1M (11 sales), last Jan 6, 2026
- Christopher Richard Anzalone, CEO: sold $24M (25 sales), last Jan 2, 2026
- Mauro Ferrari, Director: sold $1M (2 sales), last Dec 26, 2025
- William D. Waddill, Director: sold $566K (3 sales), last Dec 19, 2025
- Victoria Vakiener, Director: sold $679K (3 sales), last Dec 19, 2025
- Douglas S Ingram, Director: other filings, last Dec 16, 2025
Get free alerts when an insider at Arrowhead Pharmaceuticals, Inc files a new trade →